1. Stocks
  2. Adaptimmune Therapeutics Plc - ADR
  3. Swot
swot-logo

Adaptimmune Therapeutics Plc - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Adaptimmune Therapeutics Plc - ADR has 6 Strengths, 22 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding

Stocks with Quarter Change % less than Industry

New 52 week low today

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Lowest Momentum Scores (Technical Scores)

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

Weak Stocks (DVM)

Inefficient use of shareholder funds - ROE declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Profit to Loss Companies

Companies Increasing Debt as per Annual Report

RSI indicating price weakness

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Institutions decreased their shareholding last quarter